Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 18, 2001

View Archived Issues

Vical and Ichor form collaboration on gene-based delivery of therapeutic proteins

Lexicon grants license to DNA technology for gene targeting

GSK seeks Swedish approval of dutasteride for treatment of BPH

Preclinical studies of Inactine system demonstrate ability to reduce RBC prion proteins

Caspase inhibitor protects myocardium during septic shock by inhibiting myocyte apoptosis

Alizyme highlights product development efforts

European launch of Thyrogen under way

ESICM highlights: pharmacokinetics of drotrecogin alfa determined in PROWESS

InterMune and Boehringer Ingelheim expand partnership to develop product for ovarian cancer

Unigene awarded federal grant to aid in developing hormone for osteoporosis

Amarillo Biosciences receives grant to develop H. pylori vaccine

Further evidence indicating enhanced antiinflammatory activity for NO-releasing steroid

GSK seeks European approval of Seretide for COPD

Strontium ranelate has dual bone formation-enhancing and antiresorptive effects

Positive phase II results reported for methylnaltrexone

FDA grant and European OMP designation for Fibrillex

Mast cell chymase inhibitors discovered at Teijin

Aromatherapy shows no benefit over placebo in postoperative nausea

Cholinergic function modulators claimed for use in nicotine addiction and other disorders by Pfizer

Fujisawa identifies new aminoalcohol beta3-adrenoceptor agonists

Preparation and use of A2A receptor agonists in heart imaging

Intranasal morphine tested for relief of breakthrough pain in cancer patients

FDA clears use of Allergan's Tazorac cream for treatment of acne

Ortho-McNeil patents new series of neuropeptide Y5 receptor ligands

Hydroxamic acid-based inhibitors of sCD23 formation and TNF processing

Patent coverage gained for Gliatech's antiproperdin antibody therapies

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 11, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...